Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions
- 241 Downloads
- 17 Citations
Abstract
Tissue injury is inevitably accompanied by disruption of the endothelium and exposure of the subendothelial matrix. To generate a guidance molecule directing progenitor cells to sites of vascular lesions, we designed a bifunctional protein. The protein consists of the soluble platelet collagen receptor glycoprotein VI and an antibody to CD133 (hereafter called GPVI-CD133). In vitro and in vivo, this construct substantially mediates endothelial progenitor cell (EPC) homing to vascular lesions. Exposure of EPCs to GPVI-CD133 did not impair their capability to differentiate toward mature endothelial cells as verified by the formation of colony-forming units, the upregulation of endothelial markers CD31 and CD146 analyzed by flow cytometry or von Willebrand factor and endoglin assessed by immunofluorescence microscopy, as well as the presence of Weibel–Palade bodies using transmission electron microscopy. In vivo, GPVI-CD133 augments reendothelialization of vascular lesions. Thus, this bifunctional protein could be a potential new therapeutic option for cardiovascular diseases.
Keywords
Regenerative medicine Endothelialization Progenitor cells Stem cells Vascular injury Guidance molecule Vascular disease TherapyNotes
Acknowledgment
We acknowledge the excellent technical assistance of Sarah Gehring, Jadwiga Kwiatkowska, Heike Runge, Sandra Bundschuh, and Birgit Fehrenbacher. We thank Rupert Handgretinger for critical revision and supply of stem cells.
Funding
The study was supported by grants from the Deutsche Forschungsgemeinschaft (Graduiertenkolleg “Zellbiologische Mechanismen immunasoziierter Prozesse,” GK 794 and “Vaskuläre Medizin” [GRK 438 and MA 2186/3-1] to MG), SFB-TR19, and the Novartis Foundation and the fortüne research program of the UKT to HFL and MG. The Bio-Rad TPLSM was obtained via a grant (no. 902-16-276) from the Medical Section of the Dutch Scientific Organization. Experiments carried out by JW v.d. R, SC, and TS were financed by the Center for Regeneration Biology and Regenerative Medicine by the Carl Baresel Stiftung and Stiftung Landesbank Baden Württemberg.
Potential conflict of interest
None.
Supplementary material
Dynamic adhesion of EPCs to GPVI-CD133 in vitro (a). Under arterial shear conditions (2,000 s−1), adhesion of EPCs to collagen additionally covered with the individual components of the construct (10 μg/mL each) is shown from minute 08:30 to minute 09:00 of perfusion. Virtually no firm adhesion of EPCs could be observed (MOV 264 kb)
Dynamic adhesion of EPCs to GPVI-CD133 in vitro (b). This sequence from minute 06:00 to minute 09:00 is representative for flow chamber experiments, in which the bispecific construct (10 μg/mL) was applied. Adherent EPCs are distributed over the complete frame (MOV 3252 kb)
Recruitment of EPCs to vascular lesions by GPVI-CD133 in vivo (a). In C57BL/6J mice, the common carotid artery was injured by ligation and DCF (green)-stained EPCs were injected intravenously. When the cells were incubated with both individual components of the construct, significantly less EPCs adhered to the injured vessel wall than in (MOV 1429 kb)
Recruitment of EPCs to vascular lesions by GPVI-CD133 in vivo (b) experiments with EPCs treated with the GPVI-CD133 construct. Both films are recorded 30 min after the induction of vascular injury (MOV 2292 kb)
Z-stack movie (see also supplemental figure 1) as imaged by TPLSM of an intact, nonvital carotid artery mounted in a flow chamber (obtained from intravital microscopy experiments) (a) (MOV 3660 kb)
EPCs were incubated with the GPVI-CD133 construct, but the carotid artery is intact. Screening starts from the luminal side of the vessel. First, the endothelial monolayer (red nuclei), then the media and the adventitia become visible. The media shows smooth muscle cell nuclei (red), the adventitia fibroblasts (red nuclei) embedded in collagen (blue, SHG). No DCF stained EPCs can be observed on the luminal side of the vessel (b) (MOV 1667 kb)
References
- 1.Asahara T, Murohara T, Sullivan A, Silver M, van der ZR, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967CrossRefPubMedGoogle Scholar
- 2.Rafii S, Lyden D (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9:702–712CrossRefPubMedGoogle Scholar
- 3.Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999–1007CrossRefPubMedGoogle Scholar
- 4.Conrad S, Renninger M, Hennenlotter J, Wiesner T, Just L, Bonin M, Aicher W, Buhring HJ, Mattheus U, Mack A, Wagner HJ, Minger S, Matzkies M, Reppel M, Hescheler J, Sievert KD, Stenzl A, Skutella T (2008) Generation of pluripotent stem cells from adult human testis. Nature 456:344–349CrossRefPubMedGoogle Scholar
- 5.Cowan CA, Klimanskaya I, McMahon J, Atienza J, Witmyer J, Zucker JP, Wang S, Morton CC, McMahon AP, Powers D, Melton DA (2004) Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350:1353–1356CrossRefPubMedGoogle Scholar
- 6.Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y, Qyang Y, Bu L, Sasaki M, Martin-Puig S, Sun Y, Evans SM, Laugwitz KL, Chien KR (2006) Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127:1151–1165CrossRefPubMedGoogle Scholar
- 7.Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872CrossRefPubMedGoogle Scholar
- 8.Yu J, Vodyanik MA, Smuga-Otto K, ntosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917–1920CrossRefPubMedGoogle Scholar
- 9.Chien KR (2008) Regenerative medicine and human models of human disease. Nature 453:302–305CrossRefPubMedGoogle Scholar
- 10.Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8:1227–1234CrossRefPubMedGoogle Scholar
- 11.Massberg S, Konrad I, Bultmann A, Schulz C, Munch G, Peluso M, Lorenz M, Schneider S, Besta F, Muller I, Hu B, Langer H, Kremmer E, Rudelius M, Heinzmann U, Ungerer M, Gawaz M (2004) Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J 18:397–399PubMedGoogle Scholar
- 12.Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M, Steinhoff G (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361:45–46CrossRefPubMedGoogle Scholar
- 13.Urbich C, Dimmeler S (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95:343–353CrossRefPubMedGoogle Scholar
- 14.Lang P, Bader P, Schumm M, Feuchtinger T, Einsele H, Fuhrer M, Weinstock C, Handgretinger R, Kuci S, Martin D, Niethammer D, Greil J (2004) Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors. Br J Haematol 124:72–79CrossRefPubMedGoogle Scholar
- 15.Bühring H, Marxer A, Lammers R, Wissinger B (2002) CD133 cluster report. In: Mason D, André P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Hoøejší V, Jones Y, Meuer S, Morrissey J, Schwartz-Albiez R, Shaw S, Simmons D, Turni L, Uguccioni M, van der Schoot E, Vivier E, Zola H (eds) Leucocyte Typing VII. White Cell Differentiation Antigens. Oxford University Press, Oxford, pp 622–623Google Scholar
- 16.Jung G, Honsik CJ, Reisfeld RA, Muller-Eberhard HJ (1986) Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugates. Proc Natl Acad Sci U S A 83:4479–4483CrossRefPubMedGoogle Scholar
- 17.Langer H, May AE, Bultmann A, Gawaz M (2005) ADAM 15 is an adhesion receptor for platelet GPIIb–IIIa and induces platelet activation. Thromb Haemost 94:555–561PubMedGoogle Scholar
- 18.Choi EY, Chavakis E, Czabanka MA, Langer HF, Fraemohs L, Economopoulou M, Kundu RK, Orlandi A, Zheng YY, Prieto DA, Ballantyne CM, Constant SL, Aird WC, Papayannopoulou T, Gahmberg CG, Udey MC, Vajkoczy P, Quertermous T, Dimmeler S, Weber C, Chavakis T (2008) Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322:1101–1104CrossRefPubMedGoogle Scholar
- 19.Schafer A, Schulz C, Eigenthaler M, Fraccarollo D, Kobsar A, Gawaz M, Ertl G, Walter U, Bauersachs J (2004) Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. Blood 103:407–412CrossRefPubMedGoogle Scholar
- 20.Langer H, May AE, Daub K, Heinzmann U, Lang P, Schumm M, Vestweber D, Massberg S, Schonberger T, Pfisterer I, Hatzopoulos AK, Gawaz M (2006) Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 98:e2–e10CrossRefPubMedGoogle Scholar
- 21.Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196:887–896CrossRefPubMedGoogle Scholar
- 22.van Zandvoort M, Engels W, Douma K, Beckers L, Oude EM, Daemen M, Slaaf DW (2004) Two-photon microscopy for imaging of the (atherosclerotic) vascular wall: a proof of concept study. J Vasc Res 41:54–63CrossRefPubMedGoogle Scholar
- 23.Just L, Timmer M, Tinius J, Stahl F, Deiwick A, Nikkhah G, Bader A (2003) Identification of human cells in brain xenografts and in neural co-cultures of rat by in situ hybridisation with Alu probe. J Neurosci Methods 126:69–77CrossRefPubMedGoogle Scholar
- 24.De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capogrossi MC, Pesce M (2004) SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104:3472–3482CrossRefPubMedGoogle Scholar
- 25.Hristov M, Zernecke A, Bidzhekov K, Liehn EA, Shagdarsuren E, Ludwig A, Weber C (2007) Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res 100:590–597CrossRefPubMedGoogle Scholar
- 26.Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115:3378–3384CrossRefPubMedGoogle Scholar
- 27.Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, Zohlnhoefer D, Hoppe K, Schiemann M, Kennerknecht E, Sauer S, Schulz C, Kerstan S, Rudelius M, Seidl S, Sorge F, Langer H, Peluso M, Goyal P, Vestweber D, Emambokus NR, Busch DH, Frampton J, Gawaz M (2006) Platelets secrete stromal cell-derived factor 1α and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 203:1221–1233CrossRefPubMedGoogle Scholar
- 28.Massberg S, Gawaz M, Gruner S, Schulte V, Konrad I, Zohlnhofer D, Heinzmann U, Nieswandt B (2003) A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 197:41–49CrossRefPubMedGoogle Scholar
- 29.Muller I, Kordowich S, Holzwarth C, Spano C, Isensee G, Staiber A, Viebahn S, Gieseke F, Langer H, Gawaz M, Horwitz E, Conte P, Handgretinger R, Dominici M (2006) Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8:437–444CrossRefPubMedGoogle Scholar
- 30.Langer HF, Stellos K, Steingen C, Froihofer A, Schonberger T, Kramer B, Bigalke B, May AE, Seizer P, Muller I, Gieseke F, Siegel-Axel D, Meuth SG, Schmidt A, Wendel HP, Muller I, Bloch W, Gawaz M (2009) Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro. J Mol Cell Cardiol 47:315–325CrossRefPubMedGoogle Scholar
- 31.Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752–2760CrossRefPubMedGoogle Scholar
- 32.Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109:1801–1809CrossRefPubMedGoogle Scholar
- 33.Prater DN, Case J, Ingram DA, Yoder MC (2007) Working hypothesis to redefine endothelial progenitor cells. Leukemia 21:1141–1149CrossRefPubMedGoogle Scholar
- 34.Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95:952–958PubMedGoogle Scholar
- 35.Chavakis E, Urbich C, Dimmeler S (2008) Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol 45:514–522CrossRefPubMedGoogle Scholar
- 36.Seeger FH, Zeiher AM, Dimmeler S (2007) Cell-enhancement strategies for the treatment of ischemic heart disease. Nat Clin Pract Cardiovasc Med 4(Suppl 1):S110–S113CrossRefPubMedGoogle Scholar
- 37.Shao H, Tan Y, Eton D, Yang Z, Uberti MG, Li S, Schulick A, Yu H (2008) Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels. Stem Cells 26:1376–1384CrossRefPubMedGoogle Scholar
- 38.Sasaki K, Heeschen C, Aicher A, Ziebart T, Honold J, Urbich C, Rossig L, Koehl U, Koyanagi M, Mohamed A, Brandes RP, Martin H, Zeiher AM, Dimmeler S (2006) Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci U S A 103:14537–14541CrossRefPubMedGoogle Scholar
- 39.Oh IY, Yoon CH, Hur J, Kim JH, Kim TY, Lee CS, Park KW, Chae IH, Oh BH, Park YB, Kim HS (2007) Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood 110:3891–3899CrossRefPubMedGoogle Scholar
- 40.Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593–600CrossRefPubMedGoogle Scholar